Recent advances in immunotherapy for bladder cancer: mechanisms, clinical applications, and future perspectives
{{output}}
The past decade has witnessed a paradigm shift in the treatment of bladder cancer, propelled by significant advances in immunotherapy. Immune checkpoint inhibitors (ICIs) targeting PD-1/PD-L1 and CTLA-4, adoptive cellular therapies including chimeric antigen r... ...
